Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein

Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein

US Patent 11096989 · Granted Aug 24, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding poly2025
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof2025
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using am2025
Anti-PD-L1 antibodies and antibody-drug conjugates2025
Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy2025
Combination immunotherapy for treatment of melanoma, colon or non-small cell lun2025
Polyclonal mixtures of antibodies, and methods of making and using them2025
Fusion proteins comprising an engineered knottin peptide and uses thereof2025
Collagen-localized immunomodulatory molecules and methods thereof2025
Soluble leukemia inhibitory factor receptor polypeptides and methods of using sa2024
Methods and systems for screening using microcapillary arrays2024
Bispecific antibodies specific for treating hematological malignancies2024